IL44877A0 - Allopurinol tablet formulation - Google Patents

Allopurinol tablet formulation

Info

Publication number
IL44877A0
IL44877A0 IL44877A IL4487774A IL44877A0 IL 44877 A0 IL44877 A0 IL 44877A0 IL 44877 A IL44877 A IL 44877A IL 4487774 A IL4487774 A IL 4487774A IL 44877 A0 IL44877 A0 IL 44877A0
Authority
IL
Israel
Prior art keywords
tablet formulation
allopurinol tablet
allopurinol
formulation
tablet
Prior art date
Application number
IL44877A
Other versions
IL44877A (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL44877A0 publication Critical patent/IL44877A0/en
Publication of IL44877A publication Critical patent/IL44877A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL44877A 1973-05-23 1974-05-22 Allopurinol tablet formulation IL44877A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2462873A GB1460302A (en) 1973-05-23 1973-05-23 Tablet formulation

Publications (2)

Publication Number Publication Date
IL44877A0 true IL44877A0 (en) 1974-07-31
IL44877A IL44877A (en) 1976-11-30

Family

ID=10214700

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44877A IL44877A (en) 1973-05-23 1974-05-22 Allopurinol tablet formulation

Country Status (21)

Country Link
JP (1) JPS577128B2 (en)
AT (1) AT351167B (en)
AU (1) AU469472B2 (en)
BE (1) BE815409A (en)
CA (1) CA977279A (en)
CY (1) CY941A (en)
DE (1) DE2424950A1 (en)
DK (1) DK144261C (en)
FI (1) FI156674A (en)
FR (1) FR2230341B1 (en)
GB (1) GB1460302A (en)
HK (1) HK1378A (en)
HU (1) HU170656B (en)
IE (1) IE39283B1 (en)
IL (1) IL44877A (en)
IT (1) IT8048966A0 (en)
KE (1) KE2808A (en)
MY (1) MY7800181A (en)
NL (1) NL190436C (en)
SE (1) SE402525C (en)
ZA (1) ZA743318B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
DE3839825A1 (en) * 1988-11-25 1990-06-13 Henning Berlin Gmbh SOLIDS DISPERSIONS CONTAIN OXIPURINOL AND / OR ITS ALKALI OR EARTH ALKALISALZE
EP0719547A1 (en) * 1994-07-18 1996-07-03 Luis Cipriano Carvajal Martin Self-desintegrating compact granules used in galenic forms and containing active insoluble or hardly soluble principles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors
US3624205A (en) * 1967-04-25 1971-11-30 Burroughs Wellcome Co Treatment of hyperuricemia in humans

Also Published As

Publication number Publication date
AU469472B2 (en) 1976-02-12
FR2230341B1 (en) 1977-04-15
HK1378A (en) 1978-01-13
MY7800181A (en) 1978-12-31
AU6925274A (en) 1975-11-27
DK144261B (en) 1982-02-01
CA977279A (en) 1975-11-04
IE39283L (en) 1974-11-23
NL190436C (en) 1994-03-01
SE402525B (en) 1978-07-10
DE2424950A1 (en) 1974-12-19
JPS577128B2 (en) 1982-02-09
JPS5040721A (en) 1975-04-14
IE39283B1 (en) 1978-09-13
ZA743318B (en) 1975-05-28
FI156674A (en) 1974-11-24
NL190436B (en) 1993-10-01
BE815409A (en) 1974-11-22
IL44877A (en) 1976-11-30
DK144261C (en) 1991-02-04
AT351167B (en) 1979-07-10
HU170656B (en) 1977-07-28
CY941A (en) 1978-06-23
GB1460302A (en) 1977-01-06
SE402525C (en) 1982-11-22
NL7406873A (en) 1974-11-26
FR2230341A1 (en) 1974-12-20
IT8048966A0 (en) 1980-06-13
ATA426774A (en) 1978-12-15
KE2808A (en) 1978-02-17

Similar Documents

Publication Publication Date Title
AU7445774A (en) Cosmetics
HK13379A (en) Pyrazino-isoquinoline derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
YU35484B (en) Plug
GB1368540A (en) Rinse-wax formulation
ZA746256B (en) Decapeptides
AU6862874A (en) Plug
ZA745941B (en) Cosmetics
JPS5143759A (en) Nn * jihidorokishipuropiru * hidantoinruino seizohoho
ZA7461B (en) Pharmaceutical formulation
IL44877A0 (en) Allopurinol tablet formulation
AU6365873A (en) Bleaching formulation
AU7292674A (en) Biscuits
ZA75930B (en) Tablet formulation
AU7537774A (en) Hloride
ZA744295B (en) Addition agent
ZA743282B (en) Novel hormonic formulation
CS189672B2 (en) Hebricide agent
ZA748179B (en) Ophthlamic preparations
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
JPS5182220A (en) nn arukiru beetaa okishibuchiramaidosemisakushineetorui mataha sonoenruinoseiho
ZA744243B (en) Pharmaceutical tablet
PH14599A (en) Improved allopurinol tablet formulation